• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KSX
Click for more information
0.00% 1.5¢

KARMELSONIX LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
KSXShareholder Update23/08/11
KSXPrestigious Analyst Group Consilium Commences Covereage18/08/11
KSXResults of Meeting10/08/11
KSXFinal Director's Interest Notice04/08/11
KSXKarmelSonix Investor Presentation Update02/08/11
KSXAppendix 4C - quarterlyPRICE SENSITIVE29/07/11
KSXPaul Eisen Retires from KarmelSonix Board29/07/11
KSXResponse to ASX Query - Change of Director's Interest Notice15/07/11
KSXNotice of General Meeting and Proxy form12/07/11
KSXChange of Director's Interest Notice - RH12/07/11
KSXShareholder UpdatePRICE SENSITIVE07/07/11
KSXFurther Details on CEO Appointment22/06/11
KSXASX Waiver Granted22/06/11
KSXAppendix 3B and Section 708A Notice15/06/11
KSXKarmelSonix appoints Mr. Michael Thomas as new CEOPRICE SENSITIVE14/06/11
KSXAppendix 3B and Section 708A Notice23/05/11
KSXKarmelsonix Sales Commence in South KoreaPRICE SENSITIVE19/05/11
KSXChange in substantial holding (NG)16/05/11
KSXAppendix 3B and Section 708A Notice11/05/11
KSXShareholder Update04/05/11
KSXOmron Healthcare signs agreementPRICE SENSITIVE03/05/11
KSXAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
KSXAppendix 3B and Section 708A Notice20/04/11
KSXChange in substantial holding13/04/11
KSXChange in substantial holding13/04/11
KSXAppendix 3B and Section 708A Notice11/04/11
KSXLetter to Convertible Note Holders01/04/11
KSXKSX Completes Privates Placement and Moves to List on NasdaqPRICE SENSITIVE31/03/11
KSXAppendix 3B and Section 708A Notice30/03/11
KSXTrading HaltPRICE SENSITIVE29/03/11
KSXKSX launch of JV for At-Home Monitoring of Nocturnal AsthmaPRICE SENSITIVE22/03/11
KSXAppendix 3B17/03/11
KSXAppendix 3B and Section 708A Notice10/03/11
KSXAnalyst Group Wise-owl.com Commences Coverage of KSX07/03/11
KSXKSX Announces Launch of Home Testing in AustraliaPRICE SENSITIVE02/03/11
KSXKSX Announces Service Agreement with Childrens HospitalPRICE SENSITIVE01/03/11
KSXHalf Year AccountsPRICE SENSITIVE28/02/11
KSXReplacement Change of Director's Interest Notice (RH)24/02/11
KSXChange of Director's Interest Notice (RH)18/02/11
KSXAppendix 3B and Section 708A Notice16/02/11
KSXAppendix 4C - quarterlyPRICE SENSITIVE27/01/11
KSXShareholder Update27/01/11
KSXAppendix 3B and Section 708A Notice10/01/11
KSXChange of Director's Interest Notice (PE, PH, FP)21/12/10
KSXAppendix 3B and Section 708A Notice17/12/10
KSXResults of Annual General Meeting30/11/10
KSXKarmelSonix AGM Presentation30/11/10
KSXKSX Wins Frost and Sullivan New Product Innovation Award18/11/10
KSXKSX highlights the clinical value proposition of its Product17/11/10
KSXChange in substantial holding15/11/10
KSXKSX signs Agreements with various European DistributorsPRICE SENSITIVE11/11/10
KSXShareholder Update - November 201009/11/10
KSXAppendix 4C - quarterlyPRICE SENSITIVE29/10/10
KSXNotice of Annual General Meeting/Proxy Form29/10/10
KSXKSX Appoints Mr Bill Nicklin as Manufacturing Consultant28/10/10
KSXKarmelSonix Convertible Note Update22/10/10
KSXAppendix 3X - RH, PH, JK, FP21/10/10
KSXAppendix 3Z - NG, NI, PM, AO, HP21/10/10
KSXKSX Raises approx. $2 million via Issue of Convertible NotesPRICE SENSITIVE20/10/10
KSXKarmelSonix Announces Board RestructurePRICE SENSITIVE20/10/10
KSXTrading HaltPRICE SENSITIVE18/10/10
KSXUpdated Presentation05/10/10
KSXShareholder Update01/10/10
KSX2010 Annual Report30/09/10
KSXProposed Management and Board RestructurePRICE SENSITIVE02/09/10
KSXPreliminary Final ReportPRICE SENSITIVE31/08/10
KSXAppendix 4C - quarterlyPRICE SENSITIVE30/07/10
KSXAppendix 3Y - PE23/07/10
KSXFDA Grants Clearance for WHolter RecorderPRICE SENSITIVE19/07/10
KSXAMA approves CPT Codes for KSX TechnologyPRICE SENSITIVE28/06/10
KSXAppendix 3B and Section 708A Notice25/06/10
KSXTrading HaltPRICE SENSITIVE24/06/10
KSXKSX WHolter Service - New Revenue Model LaunchedPRICE SENSITIVE22/06/10
KSXKarmelSonix Sales and Marketing UpdatePRICE SENSITIVE15/06/10
KSXKSX Commences Shipping WHolter and Wireless PulmoTrackPRICE SENSITIVE04/05/10
KSXAppendix 4C - quarterlyPRICE SENSITIVE30/04/10
KSXSales and Marketing Update Report - Asia Pacific RegionPRICE SENSITIVE21/04/10
KSXNew US Patent Allowed for Airway Patency TechnologyPRICE SENSITIVE20/04/10
KSXAppendix 3B and Section 708A16/04/10
KSXKSX Signs Distribution Agreements in the United StatesPRICE SENSITIVE15/04/10
KSXAppendix 3Y - PM14/04/10
KSXEuropean CE Mark granted to KarmelSonix' WHolter DevicePRICE SENSITIVE08/04/10
KSXAppendix 3Y - PE15/03/10
KSXAppendix 4D For the Half Year Ended 31 December 2009PRICE SENSITIVE26/02/10
KSXAppendix 3B19/02/10
KSXKarmelSonix Signs Agreement with Second Distributor in IndiaPRICE SENSITIVE18/02/10
KSXKarmelSonix Expands Senior Sales and Marketing Team16/02/10
KSXAppendix 3X - AO15/02/10
KSXAppendix 3X - PE15/02/10
KSXAppointment of New Board Directors11/02/10
KSXAppendix 4C - quarterlyPRICE SENSITIVE29/01/10
KSXChange in substantial holding21/12/09
KSXChange in substantial holding21/12/09
KSXNews Release by Analog Devices Inc21/12/09
KSXClinical Study Accepted for Publication in Asthma Journal18/12/09
KSXAppendix 3B and Section 708A Notice17/12/09
KSXKSX Announces Australian Pharmacy Distribution Agreement10/12/09
KSXSuccessful Placement of Shares Raises Approx. $4.5mPRICE SENSITIVE09/12/09
KSXReinstatement to Official QuotationPRICE SENSITIVE09/12/09
KSXSuspension from Official QuotationPRICE SENSITIVE03/12/09
KSXShareholder Update
23/08/11
KSXPrestigious Analyst Group Consilium Commences Covereage
18/08/11
KSXResults of Meeting
10/08/11
KSXFinal Director's Interest Notice
04/08/11
KSXKarmelSonix Investor Presentation Update
02/08/11
KSXAppendix 4C - quarterly
29/07/11PRICE SENSITIVE
KSXPaul Eisen Retires from KarmelSonix Board
29/07/11
KSXResponse to ASX Query - Change of Director's Interest Notice
15/07/11
KSXNotice of General Meeting and Proxy form
12/07/11
KSXChange of Director's Interest Notice - RH
12/07/11
KSXShareholder Update
07/07/11PRICE SENSITIVE
KSXFurther Details on CEO Appointment
22/06/11
KSXASX Waiver Granted
22/06/11
KSXAppendix 3B and Section 708A Notice
15/06/11
KSXKarmelSonix appoints Mr. Michael Thomas as new CEO
14/06/11PRICE SENSITIVE
KSXAppendix 3B and Section 708A Notice
23/05/11
KSXKarmelsonix Sales Commence in South Korea
19/05/11PRICE SENSITIVE
KSXChange in substantial holding (NG)
16/05/11
KSXAppendix 3B and Section 708A Notice
11/05/11
KSXShareholder Update
04/05/11
KSXOmron Healthcare signs agreement
03/05/11PRICE SENSITIVE
KSXAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
KSXAppendix 3B and Section 708A Notice
20/04/11
KSXChange in substantial holding
13/04/11
KSXChange in substantial holding
13/04/11
KSXAppendix 3B and Section 708A Notice
11/04/11
KSXLetter to Convertible Note Holders
01/04/11
KSXKSX Completes Privates Placement and Moves to List on Nasdaq
31/03/11PRICE SENSITIVE
KSXAppendix 3B and Section 708A Notice
30/03/11
KSXTrading Halt
29/03/11PRICE SENSITIVE
KSXKSX launch of JV for At-Home Monitoring of Nocturnal Asthma
22/03/11PRICE SENSITIVE
KSXAppendix 3B
17/03/11
KSXAppendix 3B and Section 708A Notice
10/03/11
KSXAnalyst Group Wise-owl.com Commences Coverage of KSX
07/03/11
KSXKSX Announces Launch of Home Testing in Australia
02/03/11PRICE SENSITIVE
KSXKSX Announces Service Agreement with Childrens Hospital
01/03/11PRICE SENSITIVE
KSXHalf Year Accounts
28/02/11PRICE SENSITIVE
KSXReplacement Change of Director's Interest Notice (RH)
24/02/11
KSXChange of Director's Interest Notice (RH)
18/02/11
KSXAppendix 3B and Section 708A Notice
16/02/11
KSXAppendix 4C - quarterly
27/01/11PRICE SENSITIVE
KSXShareholder Update
27/01/11
KSXAppendix 3B and Section 708A Notice
10/01/11
KSXChange of Director's Interest Notice (PE, PH, FP)
21/12/10
KSXAppendix 3B and Section 708A Notice
17/12/10
KSXResults of Annual General Meeting
30/11/10
KSXKarmelSonix AGM Presentation
30/11/10
KSXKSX Wins Frost and Sullivan New Product Innovation Award
18/11/10
KSXKSX highlights the clinical value proposition of its Product
17/11/10
KSXChange in substantial holding
15/11/10
KSXKSX signs Agreements with various European Distributors
11/11/10PRICE SENSITIVE
KSXShareholder Update - November 2010
09/11/10
KSXAppendix 4C - quarterly
29/10/10PRICE SENSITIVE
KSXNotice of Annual General Meeting/Proxy Form
29/10/10
KSXKSX Appoints Mr Bill Nicklin as Manufacturing Consultant
28/10/10
KSXKarmelSonix Convertible Note Update
22/10/10
KSXAppendix 3X - RH, PH, JK, FP
21/10/10
KSXAppendix 3Z - NG, NI, PM, AO, HP
21/10/10
KSXKSX Raises approx. $2 million via Issue of Convertible Notes
20/10/10PRICE SENSITIVE
KSXKarmelSonix Announces Board Restructure
20/10/10PRICE SENSITIVE
KSXTrading Halt
18/10/10PRICE SENSITIVE
KSXUpdated Presentation
05/10/10
KSXShareholder Update
01/10/10
KSX2010 Annual Report
30/09/10
KSXProposed Management and Board Restructure
02/09/10PRICE SENSITIVE
KSXPreliminary Final Report
31/08/10PRICE SENSITIVE
KSXAppendix 4C - quarterly
30/07/10PRICE SENSITIVE
KSXAppendix 3Y - PE
23/07/10
KSXFDA Grants Clearance for WHolter Recorder
19/07/10PRICE SENSITIVE
KSXAMA approves CPT Codes for KSX Technology
28/06/10PRICE SENSITIVE
KSXAppendix 3B and Section 708A Notice
25/06/10
KSXTrading Halt
24/06/10PRICE SENSITIVE
KSXKSX WHolter Service - New Revenue Model Launched
22/06/10PRICE SENSITIVE
KSXKarmelSonix Sales and Marketing Update
15/06/10PRICE SENSITIVE
KSXKSX Commences Shipping WHolter and Wireless PulmoTrack
04/05/10PRICE SENSITIVE
KSXAppendix 4C - quarterly
30/04/10PRICE SENSITIVE
KSXSales and Marketing Update Report - Asia Pacific Region
21/04/10PRICE SENSITIVE
KSXNew US Patent Allowed for Airway Patency Technology
20/04/10PRICE SENSITIVE
KSXAppendix 3B and Section 708A
16/04/10
KSXKSX Signs Distribution Agreements in the United States
15/04/10PRICE SENSITIVE
KSXAppendix 3Y - PM
14/04/10
KSXEuropean CE Mark granted to KarmelSonix' WHolter Device
08/04/10PRICE SENSITIVE
KSXAppendix 3Y - PE
15/03/10
KSXAppendix 4D For the Half Year Ended 31 December 2009
26/02/10PRICE SENSITIVE
KSXAppendix 3B
19/02/10
KSXKarmelSonix Signs Agreement with Second Distributor in India
18/02/10PRICE SENSITIVE
KSXKarmelSonix Expands Senior Sales and Marketing Team
16/02/10
KSXAppendix 3X - AO
15/02/10
KSXAppendix 3X - PE
15/02/10
KSXAppointment of New Board Directors
11/02/10
KSXAppendix 4C - quarterly
29/01/10PRICE SENSITIVE
KSXChange in substantial holding
21/12/09
KSXChange in substantial holding
21/12/09
KSXNews Release by Analog Devices Inc
21/12/09
KSXClinical Study Accepted for Publication in Asthma Journal
18/12/09
KSXAppendix 3B and Section 708A Notice
17/12/09
KSXKSX Announces Australian Pharmacy Distribution Agreement
10/12/09
KSXSuccessful Placement of Shares Raises Approx. $4.5m
09/12/09PRICE SENSITIVE
KSXReinstatement to Official Quotation
09/12/09PRICE SENSITIVE
KSXSuspension from Official Quotation
03/12/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.